FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/01/030660 [Registered on: 21/01/2021] Trial Registered Prospectively
Last Modified On: 20/01/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic
Other (Specify) [Vati]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To study the effect of Nisha-Amalaki Churna and Shilajeet Vati in Prameha (Pre-Diabetic) 
Scientific Title of Study   A clinicopathological study on Prameha Purvarupa (Pre-Diabetic Condition) and its management with Nisha-Amalaki Churna and Shilajeet Vati 
Trial Acronym  NACSV 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Esha Dhiman 
Designation  P G Scholar 
Affiliation  Govt Ayurvedic College and Hospital Balangir 
Address  Department of Roga Nidana Evam Vikriti Vigyana Govt Ayurvedic College and Hospital Balangir

Balangir
ORISSA
767001
India 
Phone  8219083340  
Fax    
Email  dr.eshatomar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Pradip Kumar Panda 
Designation  Professor and HOD 
Affiliation  Govt Ayurvedic College and Hospital Balangir 
Address  Department of Roga Nidana Evam Vikriti Vigyana Govt Ayurvedic College and Hospital Balangir

Balangir
ORISSA
767001
India 
Phone  9437150643  
Fax    
Email  drpkpandanidan@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr Pradip Kumar Panda 
Designation  Professor and HOD 
Affiliation  Govt Ayurvedic College and Hospital Balangir 
Address  Department of Roga Nidana Evam Vikriti Vigyana Govt Ayurvedic College and Hospital Balangir

Balangir
ORISSA
767001
India 
Phone  9437150643  
Fax    
Email  drpkpandanidan@rediffmail.com  
 
Source of Monetary or Material Support  
Esha Dhiman, Department of Roga Nidana Evam and Vikriti Vigyana Govt Ayurvedic College and Hospital Balangir 
 
Primary Sponsor  
Name  Esha Dhiman 
Address  Department of Roga Nidana Evam and Vikriti Vigyana Govt Ayurvedic College and Hospital Balangir 
Type of Sponsor  Other [Government Ayurvedic College & Hospital] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Prof Dr Pradip Kumar Panda  Govt Ayurvedic College & Hospital Balangir  OPD & IPD of Govt Ayurvedic College & Hospital Balangir
Balangir
ORISSA 
9437150643

drpkpandanidan@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Govt Ayurvedic College & Hospital Balangir,   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E139||Other specified diabetes mellituswithout complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nisha-Amalaki Churna   Nisha-amalaki churna 3 gm twice daily, empty stomach for 30 days. 
Comparator Agent  Shilajeet Vati  Shilajeet Vati having (500mg) 1 vati Twice daily, empty stomach for 30 days 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Both new and treated cases will be included.
2. Patients who fulfill the diagnostic criteria.
3. Patients age between 30-65 years.
4. Patients having fasting plasma glucose 100-
125 mg%
5. Patients having oral glucose tolerance 140-
200 mg%
6. Patients with HbA1c 5.7%-6.4%

7. Patients having symptoms of Prabhuta mutrata
(frequency of micturition), pipasa (increased
thirst), kshudha (excessive appetite), kara-
pada daha (burning sensation in hand and
feet), kara-pada suptata (numbness of hand
and feet), sweda pravritti (excessive
sweating), mukha shosha (dry mouth), mukha
madhurya (sweetness in mouth), sheeta priyata
(liking for cold things) madhura shukla
mutrata (sweetness in urine).
8. Subject willing to follow the procedures as
per the study protocol and voluntarily
signing informed consent form.
 
 
ExclusionCriteria 
Details  1. Patients age <30 years and >65 years .
2. Patients having fasting plasma glucose >
125mg%
3. Patients having oral glucose tolerance >
200mg%
4. Patients with HbA1c 6.5% or more.
5. Patients having complications of diabetes
like ketoacidosis, nephropathy, neuropathy,
retinopathy, and diabetic wounds.
6. Patients having chronic, contagious infection
disease such as active tuberculosis, hepatits
B or C, or HIV
7. Pregnant and lactating females.
8. Patients having active metabolic or
gastrointestinal disease that may interfere
with nutrient absorption, metabolism,
excretion, excluding diabetes.
9. Type-1 diabetes mellitus and Type-2 diabetes
mellitus.
10. Any other patient considered not fit for
trial.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To control the symptoms of Prameha Purvarupa  To control the symptoms of Prameha Purvarupa 
 
Secondary Outcome  
Outcome  TimePoints 
Nisha-amalaki churna is more effective than Shilajeet vati individually.  31 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="15" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   25/01/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  25/01/2021 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   The study will be submitted in the form of Dissertation to Sambalpur University as a part of Post Graduate Course  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a Clinico- Pathological Study on Prameha Purvarupa i.e Pre- Diabetic condition and its management with Nisha-Amalaki Churna and Shilajeet Vati. This is done compulsory part of Post Graduate Course. Total No. of Patients to be studied is 30 with duration of 30 days.  
Close